Clinical Trial Update: The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update investigates the combined effects of myo-inositol, somatropin, and DHEA on poor ovarian responders in Phase 2 and Phase 3, with status n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poor Ovarian Responders

Drugs mentioned

• DHEA (dehydroepiandrosterone)
• Myo-inositol (myo-inositol)
• Somatropin (somatropin)

Snippet

Sponsor: Beni-Suef University | Conditions: Poor Responders | Phase 2, Phase 3 | Status: UNKNOWN